Carregant...
Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis
Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B‐cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in h...
Guardat en:
| Publicat a: | Clin Case Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250984/ https://ncbi.nlm.nih.gov/pubmed/32477538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2773 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|